Latest news

Better outcomes for head and neck cancers treated at Providence Cancer Center
A recent retrospective study finds a 96 percent two-year survival for people with advanced head and neck cancers treated at Providence with intensity modulated radiation therapy (IMRT). These outcomes far exceed historical averages, which range between 30 to 60 percent.
New Providence Cancer Center offers on-site access to psychiatric counseling
After the shock and disbelief of diagnosis, cancer patients often find themselves at greater risk for anxiety, depression, insomnia and poor appetite, says psychiatrist Brian S. Liebreich, M.D. Learn more »
Read about other support services at Providence Cancer Center.
Hope for young patients with Hodgkin's lymphoma and non-Hodgkin's lymphoma
Research into more effective therapies at Providence Cancer Center is paying off with very high quality survivorship and long life for many patients diagnosed with lymphoma, according to Lymphoma Program medical director Craig Nichols, M.D.
Andrew Weinberg, Ph.D., receives grant to continue OX40 research
The National Institutes of Health (NIH) has awarded Andrew Weinberg, Ph.D., chief of the Laboratory of Basic Immunology, a $1,350,000 grant over five years to continue his work on studying OX40.










